Page 26 - Neil Kumar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

From Aha Moment To $10 Billion Biopharma Source: Life Science Leader Follow Me On Twitter @RfwrightLSL Ever have an aha moment? Then you can likely relate to the experience of Neil Kumar, Ph.D. In 2011 he was working as a principal at Third Rock Ventures building companies within the area of genetic medicine, a job that he felt was his passion. “It’s just that we were doing it so slowly,” he shares. In this role, he saw what seemed like a plethora of innovation just sitting on academic shelves — innovations that could potentially improve the lives of patients suffering from various di...

05.03.21 -- From Aha Moment To $10 Billion Biopharma     Analytical methods are used to ensure your molecule is being produced with the desired purity. Our CDMO experts share critical success factors for your analytical program and explain how a risk-based approach can get you to your next milestone using an appropriate balance of speed, risk, and cost while ensuring quality.   The majority of my interviews have been over the phone. As for how many interviews for feature articles I’ve conducted via Zoom, the number is exactly two — both appearing in th...

A Lesson Learned The Hard Way Source: Life Science Leader Neil Kumar, Ph.D., cofounder and CEO, BridgeBio When Neil Kumar first started BridgeBio, there were no titles and no meetings. “That was a disaster,” the CEO admits. The point of this approach was toward proving that the company was a different place to work, focused just on doing cool science. Besides, Kumar says he is insanely distrustful of hierarchical systems in general, as he doesn’t believe a centralized command and control structure to be the best way to solve complex problems. “We had a bunch of people with different s...

BridgeBio Pharma and the University of California, San Diego Announce Collaboration to Advance Treatments for Genetically Driven Conditions - read this article along with other careers information, tips and advice on BioSpace

BridgeBio Pharma Enters Seven Collaborations with University Partners Share Rare Daily Staff BridgeBio Pharma announced seven separate collaborations with top academic and research institutions to support early, promising research in genetically driven diseases and cancers with clear genetic drivers. BridgeBio announced partnerships with Brown University, GlycoNet, The Lundquist Institute, Oregon Health & Science University, Roswell Park Comprehensive Cancer Center, the University of California, San Diego; and University of California, Davis. The latest set of deals brings the...